Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03082638 · ClinicalTrials.gov registry record
Identification of Gulf War Illness (GWI) Biomarkers
A clinical trial of Gulf War Illness, sponsored by Roskamp Institute.
- Completed
- Registry status
- 76
- Enrollment target
- 1
- Study location
NCT03082638 is a study of Gulf War Illness that has completed, run by Roskamp Institute. The registered enrollment target is 76 participants, below the 124-participant average among 14 other Gulf War Illness trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03082638, a study of Gulf War Illness, has completed, sponsored by Roskamp Institute.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
- 1
- Study location
Study Summary
The scientists working on this study want to use blood samples to identify components in blood, such as protein, lipids and their breakdown products to determine if they can be used for diagnosing Gulf War Illness (GWI). An additional goal is to examine the relationship of changes in these markers with the exposures and symptoms associated with GWI. The Scientists will also prepare RNA and DNA from the blood samples for genetic analyses of certain proteins known to increase the risk for GWI. This information will be one of the factors included in the analysis of results from the protein studies.
Conditions Studied
Study Locations (1)
Florida
- The Roskamp Institute, Inc. - Sarasota
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2017-01-18 |
| Est. Completion | 2022-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03082638
The ClinicalTrials.gov registry entry for NCT03082638 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 124-participant average among 14 other Gulf War Illness trials with a reported enrollment target (39% lower). The listed sponsor is Roskamp Institute, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gulf War Illness appearing as the primary indexed condition, and to 0 interventions.
NCT03082638 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03082638 about?
NCT03082638 is a clinical study titled "Identification of Gulf War Illness (GWI) Biomarkers". The scientists working on this study want to use blood samples to identify components in blood, such as protein, lipids and their breakdown products to determine if they can be used for diagnosing Gulf War Illness (GWI). An additional goal is to examine the relationship of changes in these markers w...
What is the current status of trial NCT03082638?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2017-01-18. Estimated completion is 2022-12-31.
What conditions does trial NCT03082638 study?
This clinical trial studies the following conditions: Gulf War Illness.
Who is sponsoring clinical trial NCT03082638?
This trial is sponsored by Roskamp Institute, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03082638 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gulf War Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Confirmation of Diet as a Treatment for Gulf War Illness
RECRUITING · Phase 3
-
NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
RECRUITING
-
Validating Gulf War Illness Blood Biomarkers
RECRUITING
-
Nicotinamide Riboside Clinical Trial for GWI
RECRUITING · NA
-
Ca-Mg Butyrate in GWI
RECRUITING · Phase 2
-
Mechanisms of Gulf War Illness
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.